These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27835800)

  • 1. Contribution of heteromerization to G protein-coupled receptor function.
    Gaitonde SA; González-Maeso J
    Curr Opin Pharmacol; 2017 Feb; 32():23-31. PubMed ID: 27835800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History and biological significance of GPCR heteromerization in the neuroendocrine system.
    Tadagaki K; Jockers R; Kamal M
    Neuroendocrinology; 2012; 95(3):223-31. PubMed ID: 22156565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomerization of GPCRs involved in endocrine regulation.
    Kleinau G; Müller A; Biebermann H
    J Mol Endocrinol; 2016 Jul; 57(1):R59-80. PubMed ID: 27151573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-protein-coupled receptor type A heteromers as an emerging therapeutic target.
    Guidolin D; Agnati LF; Marcoli M; Borroto-Escuela DO; Fuxe K
    Expert Opin Ther Targets; 2015 Feb; 19(2):265-83. PubMed ID: 25381716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPCR heteromers: An overview of their classification, function and physiological relevance.
    Dale NC; Johnstone EKM; Pfleger KDG
    Front Endocrinol (Lausanne); 2022; 13():931573. PubMed ID: 36111299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of G protein-coupled receptor heteromers in endocrine systems.
    Jonas KC; Hanyaloglu AC
    Mol Cell Endocrinol; 2017 Jul; 449():21-27. PubMed ID: 28115188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid-receptor-heteromer-specific trafficking and pharmacology.
    van Rijn RM; Whistler JL; Waldhoer M
    Curr Opin Pharmacol; 2010 Feb; 10(1):73-9. PubMed ID: 19846340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Techniques for Studying Oligomer Formations of G-Protein-Coupled Receptors Using Mammalian and Yeast Cells.
    Nakamura Y; Ishii J; Kondo A
    Curr Med Chem; 2016 May; 23(16):1638-56. PubMed ID: 27052183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterodimerization of g protein-coupled receptors: specificity and functional significance.
    Prinster SC; Hague C; Hall RA
    Pharmacol Rev; 2005 Sep; 57(3):289-98. PubMed ID: 16109836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of G protein-coupled receptor-heteromer identification technology to monitor β-arrestin recruitment to G protein-coupled receptor heteromers.
    See HB; Seeber RM; Kocan M; Eidne KA; Pfleger KD
    Assay Drug Dev Technol; 2011 Feb; 9(1):21-30. PubMed ID: 21133678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor heteromerization and drug discovery.
    Rozenfeld R; Devi LA
    Trends Pharmacol Sci; 2010 Mar; 31(3):124-30. PubMed ID: 20060175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring a role for heteromerization in GPCR signalling specificity.
    Rozenfeld R; Devi LA
    Biochem J; 2011 Jan; 433(1):11-8. PubMed ID: 21158738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the development of heteromer-GPCR-based drugs.
    Franco R; Martínez-Pinilla E; Ricobaraza A; McCormick PJ
    Prog Mol Biol Transl Sci; 2013; 117():143-62. PubMed ID: 23663968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G Protein-Coupled Receptor Heteromers.
    Gomes I; Ayoub MA; Fujita W; Jaeger WC; Pfleger KD; Devi LA
    Annu Rev Pharmacol Toxicol; 2016; 56():403-25. PubMed ID: 26514203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
    Ferré S; Casadó V; Devi LA; Filizola M; Jockers R; Lohse MJ; Milligan G; Pin JP; Guitart X
    Pharmacol Rev; 2014; 66(2):413-34. PubMed ID: 24515647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antibodies in developing drugs that target G-protein-coupled receptor dimers.
    Hipser C; Bushlin I; Gupta A; Gomes I; Devi LA
    Mt Sinai J Med; 2010; 77(4):374-80. PubMed ID: 20687183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G Protein-Coupled Receptor Multimers: A Question Still Open Despite the Use of Novel Approaches.
    Vischer HF; Castro M; Pin JP
    Mol Pharmacol; 2015 Sep; 88(3):561-71. PubMed ID: 26138074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Ligands Illuminate GPCR Molecular Pharmacology.
    Wacker D; Stevens RC; Roth BL
    Cell; 2017 Jul; 170(3):414-427. PubMed ID: 28753422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.
    Milligan G
    Br J Pharmacol; 2009 Sep; 158(1):5-14. PubMed ID: 19309353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the dopamine D3 receptor: an overview of drug design strategies.
    Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V
    Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.